Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Several off-label studies have shown that acamprosate can provide some clinical benefits in youth with Fragile X Syndrome (FXS), an autism spectrum disorder caused by loss of function of the highly conserved FMR1 gene.
|
29317220 |
2018 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In over two decades since the discovery of FMR1, only a single missense mutation (p.(Ile304Asn)) has been reported as causing fragile X syndrome.
|
24448548 |
2014 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The study of the neurobehavioral consequences of mutations of FMR1, the gene responsible for fragile X syndrome (FraX), has been based largely on correlations between mutation patterns and cognitive profile.
|
10208163 |
1999 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
(CGG)(n) repeat expansion in the FMR1 gene is associated with fragile X syndrome and other disorders.
|
20616364 |
2010 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Fragile X syndrome (FXS), a leading cause of inherited intellectual disability, most commonly results from an expansion of the CGG trinucleotide repeat in the fragile X mental retardation 1 (FMR1) gene to more than 200 copies (full mutation).
|
29036014 |
2017 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The Fragile X syndrome is caused by a CGG repeat expansion >200 in the promoter of the Fragile X mental retardation 1 (FMR1) gene termed full mutation (FM).
|
21476992 |
2012 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
It affects carriers of the FMR1 premutation, which may expand when passed from a mother to her children, in which case it is likely to cause fragile X syndrome (FXS), the most common inherited developmental disability.
|
27356167 |
2016 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP.
|
23235829 |
2012 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
FMRP loss of function causes Fragile X syndrome (FXS) and autistic features.
|
21784246 |
2011 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families.
|
19367323 |
2009 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms.
|
22573456 |
2012 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Fragile X syndrome is caused by loss of function of a single gene encoding the Fragile X Mental Retardation Protein (FMRP).
|
24204304 |
2013 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Absence of the fragile X mental retardation protein (FMRP) causes fragile X syndrome, the most common form of hereditary mental retardation.
|
15381419 |
2004 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Greater than 200 CGG repeats in the 5'UTR of the FMR1 gene lead to epigenetic silencing and lack of the FMR1 protein, causing fragile X Syndrome.
|
24591415 |
2014 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Fragile X syndrome (FXS), the most common cause of inherited intellectual disability, is due to the expansion over 200 CGGs and methylation of this polymorphic region, in the 5'-UTR (untranslated region) of FMR1 (Xq27.3).
|
27784894 |
2017 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Fragile X syndrome and deletions in FMR1: new case and review of the literature.
|
9375726 |
1997 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Furthermore, they strengthen the connection between fragile X syndrome and loss of the RNA binding activity of FMR1.
|
8156595 |
1994 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We conclude that mental retardation associated with the I304N mutation, and likely the Fragile-X syndrome more generally, may relate to a crucial role for RNAs harboring the kissing complex motif as targets for FMRP translational regulation.
|
15805463 |
2005 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Since standard molecular testing does not include the analysis of the FMR1 coding region, the prevalence of point mutations causing FXS is not well known.
|
25171808 |
2015 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Memory and attention processing were examined in a group of 15 adult Fragile-X syndrome (FXS) males with Fragile-X mental retardation 1 (FMR-1) full mutation and compared to two control groups: a learning disabled (LD) control and a normal functioning control.
|
11224914 |
2001 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A dynamic mutation in the fragile X mental retardation 1 gene, FMR1, was found to cause fragile X syndrome almost 20 years ago.
|
21196228 |
2011 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by mutations in the <i>FMR1</i> gene that inactivate expression of the gene product, the fragile X mental retardation 1 protein (FMRP).
|
28894415 |
2017 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This study was undertaken to determine the relative impact of three molecular characteristics of the FMR1 mutation--number of CGG repeats, methylation status, and X inactivation ratio--on the cognitive involvement of female carriers of fragile X syndrome.
|
8301764 |
1994 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We propose a contribution of Tdrd3 to FMRP-mediated translational repression and suggest that the loss of the FMRP-Tdrd3 interaction caused by the I304N mutation might contribute to the pathogenesis of Fragile X syndrome.
|
18664458 |
2008 |
Fragile X Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
As proof-of-principle applications, we established duplex assays to examine the FMR1 promoter in individuals with fragile-X syndrome and the SNRPN promoter in individuals with Prader-Willi syndrome or Angelman syndrome, and a multiplex assay to simultaneously detect hypermethylation of seven genes (ID4, APC, RASSF1A, CDH1, ESR1, HIN1 and TWIST1) in breast cancer cell lines and tissues.
|
17998253 |
2007 |